Evidence map›Paper›PMID 40244684›Full record

ArticleeLife2025

Cell type-specific driver lines targeting the

Tanya Wolff, Mark Eddison, Nan Chen, Aljoscha Nern, Preeti Sundaramurthi, Divya Sitaraman, Gerald M Rubin

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Octopamine instructs head direction plasticity.bioRxiv : the preprint server for biology · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Tanya WolffJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States.
Mark EddisonJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States.
Nan ChenJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States.
Aljoscha NernJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States.
Preeti SundaramurthiDepartment of Psychology, College of Science, California State University, Hayward, United States.
Divya SitaramanDepartment of Psychology, College of Science, California State University, Hayward, United States.ORCID https://orcid.org/0000-0003-1197-0355
Gerald M RubinJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States.ORCID https://orcid.org/0000-0001-8762-8703

Funding

Dopamine regulation of sleep and arousalR15GM125073 · NIGMS · UNIVERSITY OF SAN DIEGO · PI SITARAMAN, DIVYA · 2017 to 2025
$951k
National Science Foundation IOS 2042873NIGMS NIH HHS R15 GM125073NIH HHS NIH 2R15GM125073-03
6 · The paper itself

Abstract

The central complex (CX) plays a key role in many higher-order functions of the insect brain including navigation and activity regulation. Genetic tools for manipulating individual cell types, and knowledge of what neurotransmitters and neuromodulators they express, will be required to gain mechanistic understanding of how these functions are implemented. We generated and characterized split-GAL4 driver lines that express in individual or small subsets of about half of CX cell types. We surveyed neuropeptide and neuropeptide receptor expression in the central brain using fluorescent in situ hybridization. About half of the neuropeptides we examined were expressed in only a few cells, while the rest were expressed in dozens to hundreds of cells. Neuropeptide receptors were expressed more broadly and at lower levels. Using our GAL4 drivers to mark individual cell types, we found that 51 of the 85 CX cell types we examined expressed at least one neuropeptide and 21 expressed multiple neuropeptides. Surprisingly, all co-expressed a small molecule neurotransmitter. Finally, we used our driver lines to identify CX cell types whose activation affects sleep, and identified other central brain cell types that link the circadian clock to the CX. The well-characterized genetic tools and information on neuropeptide and neurotransmitter expression we provide should enhance studies of the CX.

Indexed as

BrainDrosophilaDrosophila melanogasterNeuropeptidesSleepAnimalsDrosophila ProteinsGene Expression RegulationIn Situ Hybridization, FluorescenceNeuronsReceptors, NeuropeptideDrosophila ProteinsNeuropeptidesReceptors, Neuropeptidecell typescentral complexD. melanogasterdriver linesgeneticsgenomicsneuropeptidesneuroscienceneurotransmitterssleep

Identifiers

PMID40244684
PMCPMC12005719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.